Health ❯ Chronic Conditions ❯ Obesity

Diabetes

Hypertension Insulin Resistance Cardiovascular Disease Mental Health High Cholesterol Metabolic Disorders Impact on Pregnancy Severe Hypertriglyceridemia Health Risks Treatment Options Microbiota Influence Lifestyle Management Medication Management Pre-diabetes Weight Management Cardiovascular Diseases Heart Disease Hormonal Changes Sleep Apnea

Eli Lilly Breaks Ground on $6.5 Billion Houston Campus to Make Oral GLP-1 Pill

The company says the Generation Park site will boost domestic drug production and train local workers while state incentives support the deal.

Oxford Review Finds GLP-1 Weight Loss Largely Lost Within About Two Years After Stopping

Six Midlife Depressive Symptoms Tied to Higher Dementia Risk Decades Later

Ionis’ Olezarsen Slashes Triglycerides, Cuts Pancreatitis in Phase 3 Trials

CDC Study Finds Most U.S. Women Carry Modifiable Risks for Birth Defects